Photodynamic Therapy for Non-Melanoma Skin Cancers
AbstractNon‐melanoma skin cancer (NMSC) is traditionally treated with surgical excision. Nonsurgical methods such as cryotherapy and topical chemotherapeutics, amongst other treatments, are other options. Actinic keratosis (AKs) are considered precancerous lesions that eventually may progress to squamous cell carcinoma (SCC). Photodynamic therapy (PDT) offers an effective treatment for AKs, and is also effective for superficial basal cell carcinoma (BCC). Nodular BCC and Bowen’s disease (SCC in situ) have shown acceptable response rates with PDT, although recurrence rates are higher for these two NMSC subtypes. Methylaminolevulinate (MAL) PDT is a more effective treatment option than 5‐aminolevulinic acid (ALA) PDT for nodular BCC. Several studies have shown that PDT results in superior cosmetic outcomes compared to surgical treatment. PDT is overall well‐tolerated, with pain being the most common side effect. View Full-Text
Share & Cite This Article
Cohen, D.K.; Lee, P.K. Photodynamic Therapy for Non-Melanoma Skin Cancers. Cancers 2016, 8, 90.
Cohen DK, Lee PK. Photodynamic Therapy for Non-Melanoma Skin Cancers. Cancers. 2016; 8(10):90.Chicago/Turabian Style
Cohen, Diana K.; Lee, Peter K. 2016. "Photodynamic Therapy for Non-Melanoma Skin Cancers." Cancers 8, no. 10: 90.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.